Ingredion’s £1.6 Billion Cash Deal for Tate & Lyle Nears Completion — Ingredion Incorporated

Event summary

Shareholders of Tate & Lyle accepted Ingredion’s all-cash offer of 595 pence per share, announced on July 28, 2026.
The transaction is expected to close in the second half of 2027, pending regulatory approvals.
Ingredion anticipates $130 million in run-rate net cost synergies by the end of 2030 and adjusted EPS accretion in the first year post-completion.

The big picture

The acquisition positions Ingredion as a global leader in ingredient solutions, enhancing its innovation and formulation capabilities. This deal reflects broader industry trends of consolidation among food ingredient providers aiming to strengthen their market position amid shifting consumer demands. The combined entity’s revenue is expected to exceed $7 billion annually.

What we're watching

Regulatory Hurdles: The pace at which Ingredion secures necessary regulatory approvals will determine the timeline for closing the deal.
Integration Challenges: How effectively Ingredion integrates Tate & Lyle’s operations will impact the realization of projected synergies and long-term growth.
Market Dynamics: Whether the combined entity can leverage its expanded capabilities to address evolving consumer preferences for healthy, affordable food products.